abstract |
The present invention in particular for use simultaneously, together, separately or sequentially for the treatment of proliferative diseases, (a) HDAC inhibitors; And (b) anti-thrombocytopenia drugs It relates to a combination comprising a. The invention also relates to pharmaceutical compositions or products comprising such combinations, or methods of using such combinations. |